Ruth Coleman

Investor

About

A biomedical scientist by background, I joined a Health Tech start-up as the 5th employee. I helped build out the customer base and quickly became obsessed with start-ups and technology. I then did venture building in Australia where we acquired intellectual property from universities and built businesses around it. I ran some of our Med Tech spin outs, where we raised capital, ran trials and had a team of engineers who did the product development. COVID hit and we pivoted, managing to secure a $38m Federal contract to stand up a supply chain of emergency ventilators from scratch in nine months.

In 2022, I got the opportunity to join Mercia Ventures based out of London office. Since joining the fund I have invested in and worked with eight companies supporting their growth.

At Mercia, I am primarily focused on investments in technology investments across Health and Life Sciences and Enterprise Software at the early stage.

Grit, drive and the ability to bring others along - that’s what sets great founders apart.
Why we invested

Why we invested: Laverock Theraputics